ライフサイエンスコーパス: angiographic

1 Imaging was performed using angiographic 3 x 3-mm and 6 x 6-mm SS-OCT scans to gener

2 cker in sectors with than in sectors without angiographic abnormalities (421 +/- 102.4 mum vs 397.6 +

3 e certain similarities in the structural and angiographic abnormalities eventually produced.

4 The observed coronary angiographic abnormalities included tortuosity in all ca

5 However, we observed several coronary FMD angiographic abnormalities with corresponding optical co

6 relationship between choroidal thickness and angiographic abnormalities.

7 o a greater extent in areas characterized by angiographic abnormalities.

8 Each procedure included an additional angiographic acquisition performed twice, once with and

9 The post-IVL angiographic acute luminal gain was 0.83+/-0.47 mm, and

10 MB resulted in different patterns of aqueous angiographic AHO improvement whose further understanding

11 re placed in regions of baseline low or high angiographic AHO in each eye (n = 2 eyes with enough spa

12 At baseline, all eyes showed segmental angiographic AHO patterns.

13 ography was utilized to query alterations to angiographic AHO patterns.

14 giography established initial baseline nasal angiographic AHO patterns.

15 The angiographic analysis is limited by the inability to vis

16 se of this study was to evaluate the 9-month angiographic and 12-month clinical outcomes of the FANTO

17 Use of CT pulmonary angiographic and admission data from administrative data

18 these lesions, with special consideration of angiographic and clinical outcomes and periprocedural co

19 verolimus-eluting stents because of the best angiographic and clinical outcomes, and DCB because of i

20 e repartition of microspheres was studied by angiographic and histological analyses.

21 ase series describing findings suggestive of angiographic and intracoronary manifestations of coronar

22 Study eye eligibility required angiographic and OCT evidence of choroidal neovasculariz

23 Angiographic and OCT findings were compared with a contr

24 We present angiographic and optical coherence tomography (OCT) find

25 The present study investigated angiographic and optical coherence tomography findings i

26 Secondary end points included angiographic and safety outcomes.

27 changes in the retina using volume-rendered angiographic and structural OCT.

28 An independent core laboratory adjudicated angiographic and ultrasound parameters.

29 ow confidence, 4 = absolutely certain) on MR angiographic and UTE images.

30 independent clinical event adjudication and angiographic and wound core laboratories 358 CLI patient

31 Measure: Epidemiologic, clinical, OCT, AVF, angiographic, and electrophysiological data at baseline

32 this study was to describe the demographic, angiographic, and procedural characteristics alongside c

33 e, SYNTAX score 33 +/- 7) were included, and angiographic- and fluoroscopic-guided vascular access wa

34 of Impella using a standardized protocol for angiographic- and fluoroscopic-guided vascular access wa

35 1%) decisions, participants relied solely on angiographic appearance that was discordant in 47% with

36 Angiographic assessment after a median follow-up of 345

37 he ISCHEMIA trial, an invasive strategy with angiographic assessment and revascularization did not re

38 The correlation between angiographic assessment of coronary stenoses and fractio

39 r (the SYNTAX score reflects a comprehensive angiographic assessment of the coronary vasculature, wit

40 been established before and careful OCT and angiographic assessment of this region is warranted.

41 zed as obstructive (>=70% stenosis by visual angiographic assessment) or nonobstructive, and as thin-

42 radiologists performed detailed radiological angiographic assessments.

43 ing the ischemic time, ST-segment elevation, angiographic blush grade, and CFR, IMR has superior clin

44 artery disease (CAD) stratified by detailed angiographic burden of CAD or left ventricular ejection

45 f prior myocardial infarction, and burden of angiographic CAD (P<0.001), they demonstrated greater ri

46 as associated with outcomes independently of angiographic CAD and modified the effect of early revasc

47 ciated apolipoproteins, for the detection of angiographic CAD and outcomes.

48 The extent of angiographic CAD is an indicator of post-MI HF regardles

49 t to investigate the impact of sex, CFR, and angiographic CAD severity on adverse cardiovascular even

50 The extent of angiographic CAD was determined at baseline and categori

51 The extent and severity of angiographic CAD were estimated by using the CAD prognos

52 ht to determine the association between CFR, angiographic CAD, and cardiovascular outcomes.

53 In a cohort of 1066 angiographic cases and 1011 controls, homozygous carrier

54 Patients with only mild angiographic CAV have significantly better outcomes than

55 l to prasugrel was associated with high-risk angiographic characteristics (thrombotic, long, and bifu

56 This study sought to describe the angiographic characteristics and outcomes in patients pr

57 We compared the clinical, angiographic characteristics and outcomes of 3486 CTO in

58 Baseline demographic and angiographic characteristics were also evaluated.

59 echocardiographic, computed tomographic, and angiographic characteristics were retrospectively collec

60 Baseline clinical and angiographic characteristics were similar between the gr

61 investigated occurrence rates, clinical and angiographic characteristics, and possible mechanisms of

62 Thus, we assessed the clinical usefulness, angiographic characteristics, and safety of intracoronar

63 ust for differences in baseline clinical and angiographic characteristics, yielding a total of 326 ma

64 ly pronounced in patients with both of these angiographic characteristics.

65 ICG angiographic CNV surface areas were measured at baseline

66 he SB in-segment diameter stenosis among the angiographic cohort was lower in the bifurcation stent g

67 monstrated a significant interaction between angiographic complexity (as assessed by the SYNTAX score

68 After angiographic confirmation of ST, OCT imaging of the culp

69 nvited for clinical and computed tomographic angiographic control 1 year after BVS implantation.

70 By angiographic core laboratory analysis, lesions in women

71 2- and 3-vessel disease versus those from an angiographic core laboratory analysis.

72 nosis severity was measured using QCA in the angiographic core laboratory in 3,851 patients with 5,35

73 mized to PCI (n=914) versus CABG (n=926) had angiographic core laboratory SS assessment.

74 .5+/-9.3 (range 5-74); 24.1% of patients had angiographic core laboratory-assessed SS >=33.

75 our-year outcomes were examined according to angiographic core laboratory-assessed SS using multivari

76 Diabetes mellitus and angiographic coronary artery disease complexity are inte

77 Young women, despite having less severe angiographic coronary artery disease, have an increased

78 higher troponin values, and have more severe angiographic coronary artery disease.

79 nclusions and Relevance: Among patients with angiographic coronary disease treated with statins, addi

80 Interventions: Participants with angiographic coronary disease were randomized to receive

81 There was no fluorescein angiographic correlate to these lesions.

82 on spectral-domain OCT, with no fluorescein angiographic correlate.

83 stic regression model for the presence of an angiographic culprit lesion and internally validated wit

84 d for cystoid spaces and integrated into the angiographic data for subsequent volume rendering.

85 However, serial studies in which angiographic data were available from the past as also w

86 Echocardiographic and angiographic data were evaluated by an independent core

87 revascularization, or missing demographic or angiographic data were excluded.

88 patients and its pertinence with respect to angiographic data.

89 r by a panel of WISE cardiologists masked to angiographic data.

90 Recurrence, based on angiographic demonstration of leakage, or chronic vascul

91 chronic vascular arrest, confirmed based on angiographic demonstration of peripheral ischemia, was n

92 Clinical, procedural, and angiographic details were abstracted from medical record

93 pipeline optimization tool (TPOT) to predict angiographic diagnoses of coronary artery disease (CAD).

94 formed, we compared the respective values of angiographic diameter stenosis (DS) and fractional flow

95 A angioplasty and stenting or DA in terms of angiographic diameter stenosis at 6 months and target le

96 The median angiographic diameter stenosis of the randomized lesions

97 predominant donor vessel FFR correlated with angiographic (%) diameter stenosis severity (r=0.44; P=0

98 The extent and severity of angiographic disease were estimated with the use of the

99 who experienced EF recovery had less severe angiographic disease, lower alcohol use, and a lower bur

100 ts at high risk of graft loss even with mild angiographic disease.

101 Spectral-domain OCT detected all cases of angiographic edema and areas of outer retinal dysfunctio

102 However, MgBRS was associated with a lower angiographic efficacy, a higher rate of target lesion re

103 The secondary angiographic endpoint (powered for superiority) was in-s

104 antly cardiac pathogeneses within 9 years of angiographic evaluation.

105 ome (ACS) or stable angina, in whom there is angiographic evidence for obstructive coronary artery di

106 n records of all patients with diabetes with angiographic evidence of 2- or 3-vessel CAD who were tre

107 entify the minority of patients with AIS and angiographic evidence of a culprit lesion.

108 Half of all AIS patients had no angiographic evidence of coronary artery disease.

109 556 adult ACS or stable angina patients with angiographic evidence of obstructive coronary artery dis

110 An additional preprocedural CC angiographic examination may not be required in TAVR can

111 ithm on radiology reports, each CT pulmonary angiographic examination was classified as positive or n

112 male and female phantoms was observed for CT angiographic examination.

113 of COVID-19 patients underwent CT pulmonary angiographic examinations diagnosing PE.

114 nd sustained decrease in use of CT pulmonary angiographic examinations in the evaluation of inpatient

115 onary angiography (26.0 to 22.8 CT pulmonary angiographic examinations per 1000 admissions before and

116 ry angiography or percentage of CT pulmonary angiographic examinations positive for acute PE after CD

117 ngiography yield (percentage of CT pulmonary angiographic examinations that were positive for acute P

118 ve PE diagnoses/total number of CT pulmonary angiographic examinations) was compared in patients in w

119 d, 5287 patients underwent 5892 CT pulmonary angiographic examinations.

120 iable predictors of MI included clinical and angiographic factors (acute coronary syndromes presentat

121 Both clinical and angiographic factors and social determinants of health,

122 ailure in an alternative model that included angiographic failure or death before angiography as the

123 characteristics were analyzed for classical angiographic features (junctions, lengths) wherein we ob

124 t even after adjustment for all clinical and angiographic features (odds ratio: 0.81; 95% confidence

125 however, the association of these SNPs with angiographic features of neovascular AMD has been incons

126 Angiographic features of SCAD are associated with extrac

127 e, predisposing and precipitating stressors, angiographic features, revascularization, use of medicat

128 The only angiographic finding associated with angina was a poorly

129 The only 1-year angiographic finding significantly associated with angin

130 Late angiographic findings (89.3% of eligible patients), incl

131 In these patients, coronary angiographic findings (excluding dissected segments) wer

132 g the Seattle Angina Questionnaire (SAQ) and angiographic findings after coronary artery bypass graft

133 al FFR values remains often elusive based on angiographic findings alone.

134 to assess which clinical characteristics and angiographic findings are associated with self-reported

135 e modeling identified clinical variables and angiographic findings associated with angina.

136 Angiographic findings in dome-shaped macula suggest the

137 We aimed to investigate coronary angiographic findings in unselected out-of-hospital card

138 Relevant angiographic findings included maximal stenosis and (for

139 We also discussed CT angiographic findings of this case.

140 Whereas admission hemodynamics and angiographic findings were all well-balanced and revascu

141 FE MR angiographic findings were consistent with correlative p

142 Peripheral angiographic findings, angiographic image acquisition ti

143 On the basis of the CT pulmonary angiographic findings, chromogranin A and 5-hydroxyindol

144 amera appear to correlate well with invasive angiographic findings, including maximal stenosis and FF

145 MI, even after accounting for differences in angiographic findings, revascularization, and other conf

146 d March 31, 2016, we examined the incidence, angiographic findings, treatment (including revasculariz

147 ata on procedure duration, number of passes, angiographic findings, type of stent retriever used, and

148 esence of discordant stress test results and angiographic findings.

149 Catheter angiography confirmed the CT angiographic findings.

150 ial fat resulted in deep lesions with normal angiographic flow.

151 AD revascularization and had 12- to 18-month angiographic follow-up (n=1539) were included.

152 Angiographic follow-up at 25 months was completed in 167

153 Patients were scheduled for angiographic follow-up at 6 months, and a subgroup of pa

154 Three-year systematic angiographic follow-up revealed no significant differenc

155 Angiographic follow-up was available for 4975 (84%) of 5

156 Angiographic follow-up was performed in consecutive pati

157 minimal lumen diameter at the 6- to 9-month angiographic follow-up.

158 ary outcome was percent diameter stenosis at angiographic follow-up.

159 ic function and filling pressures to augment angiographic grading of cardiac allograft vasculopathy (

160 prevalence gap of 15% or greater between the angiographic groups.

161 rage at 6-month follow-up in comparison with angiographic guidance alone.

162 trut coverage at 6 months in comparison with angiographic guidance only.

163 ng in a larger postprocedure lumen than with angiographic guidance.

164 Peripheral angiographic findings, angiographic image acquisition time, and any complicatio

165 ons in total x-ray energy with no decline in angiographic image quality.

166 the afferent vessel was identified from the angiographic images and marked at the slit lamp using a

167 d to overlay vascular calcification on FE MR angiographic images as composite fused three-dimensional

168 lysis of the OCT B-scans compared to the OCT angiographic images demonstrated that the CNV correspond

169 mistletoe sign on cardiac MR and coronary CT angiographic images is probably rare, but it might be a

170 Capturing of angiographic images took a mean time of 7.09 minutes.

171 The angiographic images were examined to define the presence

172 diography-gated dual-source multidetector CT angiographic images were used from 250 prospectively enr

173 On reconstructed 50-phase CT angiographic images, aortic strain and deformation were

174 fluorescence on late-phase indocyanine green angiographic images.

175 oviders who placed an order for CT pulmonary angiographic imaging about the pretest probability of th

176 With CC angiographic imaging as the reference standard, the accu

177 differences in use and yield of CT pulmonary angiographic imaging before and after CDS.

178 Subsequent angiographic imaging of other vascular beds was negative

179 Time-resolved SL MR angiographic imaging over two cardiac cycles provided a

180 There was agreement between CT and CC angiographic imaging regarding graft patency in 114 of 1

181 r identifying collaterals are contrast-based angiographic imaging techniques, which are not possible

182 with CT for greater than 70% stenosis at CC angiographic imaging was 100%.

183 source CT system) and coronary catheter (CC) angiographic imaging were retrospectively analyzed.

184 ency in 114 of 115 grafts identified with CC angiographic imaging.

185 However, the adjustment for baseline angiographic imbalances discarded an influence of stent

186 ents were divided into 2 groups according to angiographic in-scaffold late lumen loss (LLL) <0.5 or >

187 zotarolimus-eluting stent, P=0.75); 13-month angiographic in-stent late lumen loss was 0.22+/-0.41 mm

188 Angiographic incidence of CAV was 5%, 15%, and 28% at 2,

189 (RV/LV) diameter ratio, and modified Miller angiographic index following ultrasound-assisted cathete

190 roves reclassification compared with any one angiographic index.

191 diabetics, the relationship between FFR and angiographic indices was particularly weak (C statistics

192 stenotic plaques, based on studies in which angiographic information was available from many months

193 ation, PDT treatment parameters, fluorescein angiographic information, optical coherence tomography (

194 endoscopy, computed tomographic angiography, angiographic intervention, serial imaging, and clinical

195 chniques such as laparoscopy, endoscopy, and angiographic intervention.

196 The time between angiographic key steps for patients who underwent GA and

197 thout prior revascularization (N = 1,550) by angiographic laboratory investigators masked to patient

198 d group than in the control stent group, and angiographic late loss of the MGuard was consistent with

199 The primary endpoint was angiographic late lumen loss (LLL) at 9 months.

200 o-primary endpoint is the non-inferiority of angiographic late luminal loss.

201 Eyes with baseline fluorescein angiographic leakage were more likely to improve than th

202 Baseline angiographic lesion criteria were not significantly asso

203 ES/BES) were not superior to BVS in terms of angiographic LLL and clinical outcomes.

204 Between 6 months/1 year and 5 years, angiographic luminal late loss remained unchanged (B1: 0

205 iple studies that had measured the degree of angiographic luminal narrowing in culprit plaques months

206 Angiographic manifestations of coronary FMD aside from d

207 The final in-stent angiographic minimum lumen diameter was 2.99+/-0.48 mm i

208 Secondary outcomes included final in-stent angiographic minimum lumen diameter, procedure time, and

209 The incidence of angiographic no reflow (NR) and microvascular obstructio

210 ation) challenging the notion that FFR after angiographic optimization is fixed because of the underl

211 ry patency was 100%, while the overall final angiographic or clinical success was 85.7%.

212 equency lesions (R(2)=0.57; P=0.03), with no angiographic or histopathologic signs of coronary artery

213 intervention in any subset defined by either angiographic or ischemic severity.

214 There were no significant differences in angiographic or OCT findings between BVS and metallic st

215 yze 1-year clinical and computed tomographic angiographic outcomes after BVS implantation in STEMI.

216 agement strategies and techniques as well as angiographic outcomes and complications related to stent

217 To compare clinical and angiographic outcomes between monitored anesthesia care

218 ns with the use of modified Rankin Score and angiographic outcomes were evaluated initially postembol

219 afe and offers excellent 1-year clinical and angiographic outcomes.

220 trol between groups of diverging clinical or angiographic outcomes.

221 To correlate the fundoscopic, fluorescein angiographic, oximetric, and optical coherence tomograph

222 Angiographic parameters included panretinal leakage inde

223 The main secondary end points included angiographic parameters of restenosis, device-oriented c

224 Quantitative angiographic parameters were evaluated with a semiautoma

225 The primary end point was 3-year angiographic patency.

226 ons led to faster development of fluorescein angiographic patterns (3.1-fold; p = 0.02).

227 One-year primary outcome of angiographic percent diameter stenosis was 33.6+/-17.7%

228 nges including capillary dropout, late-phase angiographic posterior and peripheral vascular leakage (

229 rpose To develop a computed tomographic (CT) angiographic postprocessing protocol with two- and three

230 nts of the primary end point and the device, angiographic, procedural, and clinical success rates.

231 Device, angiographic, procedural, and clinical success was achie

232 rate fluid management in patients undergoing angiographic procedures is of critical importance in lim

233 A total of 161 angiographic procedures were performed during the study

234 her SPK (n = 25) or LDK (n = 17), we studied angiographic progression of CAD between baseline (pretra

235 There was no difference in adjusted angiographic quality score between the cohorts (PR 15, 7

236 There was only modest agreement between angiographic readings in clinical practice and those fro

237 Angiographic recanalization before PCI, ST-segment resol

238 Angiographic recanalization prior to PCI was seen in 12

239 olve thrombi (sonothrombolysis) and increase angiographic recanalization rates in patients with ST-se

240 sus 2 (4%) PCI-only patients before PCI, and angiographic recanalization was 48% in high MI/PCI versu

241 The percentage of stent oversizing to angiographic reference vessel diameter (RVD) was calcula

242 ith enough space to place one stent in a low angiographic region and the other stent in a high angiog

243 graphic region and the other stent in a high angiographic region).

244 = 8 eyes with two stents both placed in high angiographic regions; n = 4 eyes with enough space to pl

245 enough space to place two stents in both low angiographic regions; n = 8 eyes with two stents both pl

246 received endovascular treatment and achieved angiographic reperfusion (score on Thrombolysis in Cereb

247 Delays in time to angiographic reperfusion lead to a decreased likelihood

248 DS angiographic reports were reviewed for causative abnorma

249 ealed that time from groin puncture to final angiographic result was shorter with patients under GA t

250 The time from groin puncture to the final angiographic result with GA, at 72 minutes (IQR, 45-109

251 roke in the anterior circulation in terms of angiographic results and procedure duration was improved

252 >5 days, overall morbidity and mortality and angiographic results at 1 year.

253 EES provided superior long-term clinical and angiographic results compared with DEB.

254 within 72 hours of symptom onset, initial DS angiographic results negative for aneurysm, and two DSA

255 Drug-eluting technologies improve 12-month angiographic results of femoropopliteal (FP) interventio

256 Angiographic results were excellent without evidence of

257 rformed to identify risk factors (midterm MR angiographic results, aneurysm characteristics, retreatm

258 ascular scaffolds is feasible with excellent angiographic results.

259 We evaluated 1-year clinical and angiographic results.

260 ssociated with significantly higher rates of angiographic revascularization at 24 hours (75.8% vs 34.

261 s, functional independence (mRS score, 0-2), angiographic revascularization at 24 hours, symptomatic

262 oved functional outcomes and higher rates of angiographic revascularization, but no significant diffe

263 Majority had type 2 angiographic SCAD (67.0%), only 29.1% had type 1, and 3.

264 Angiographic SCAD diagnosis was confirmed by 2 experienc

265 -SCAD had fibromuscular dysplasia and type 2 angiographic SCAD.

266 with each patient having undergone one 4D CT angiographic scan.

267 pretreatment and 24-hour magnetic resonance angiographic scans, National Institutes of Health Stroke

268 vents similar to those of subjects with high angiographic scores, and those with low CFR or high CAD

269 These data support the use of angiographic screening and clinical examination in immed

270 patients with intracranial aneurysm, (c) MR angiographic screening every 5 years with endovascular t

271 Patients with angiographic serial coronary artery disease scheduled fo

272 ansient or persistently improved fluorescein angiographic signal (11.2-fold; p = 0.014).

273 Angiographic signal and patterns before and after TMB.

274 eye, for each stent TMB in initially low ICG angiographic signal regions showed transient or persiste

275 artery bypass grafting, or documentation of angiographic stenosis of 50% or more in at least one cor

276 res were associated with greater severity of angiographic stenosis.

277 Serial angiographic studies also have demonstrated a sudden rap

278 Two readers scored the MR angiographic studies for vessel signal intensity and sha

279 ospective review of 322 computed tomographic angiographic studies that were performed in patients bef

280 he final cohort of 48 336 patients, 58.2% of angiographic studies were classified as appropriate, 10.

281 However, angiographic studies within 3 months before myocardial i

282 rtality rate was 26.8% (30 of 112 patients), angiographic success rate was 95.5% (107 of 112 patients

283 ad hoc coil embolization was performed with angiographic success.

284 adverse cardiac events, and 2 (9%) evaluated angiographic success.

285 rial/Phantom studies were performed with two angiographic systems, FD10 Allura Xper and FD10 Allura C

286 use of adjunctive anti-rx shields under the angiographic table during transradial coronary procedure

287 group 2 (adjunctive anti-rx shield under the angiographic table).

288 e compared between patients with and without angiographic TCL.

289 Angiographic techniques have been limited by their quali

290 iography (ICGA), and the images from these 3 angiographic techniques were compared.

291 Reperfusion was assessed with angiographic Thrombolysis in Cerebral Infarction scores

292 icipants losing fewer than 15 ETDRS letters, angiographic total lesion size, choroidal neovasculariza

293 ry, presenting characteristics (clinical and angiographic), underlying etiology, management, and card

294 Adjustment was based on 15 clinical and angiographic variables, including anatomic SYNTAX score,

295 sk for graft loss even in children with mild angiographic vasculopathy (p < 0.0001).

296 graft loss even in the presence of only mild angiographic vasculopathy.

297 scaffold versus the Xience metallic stent in angiographic vasomotor reactivity after administration o

298 Outcomes included patient- and graft-level angiographic VGF (>/=75% stenosis or occlusion).

299 [CS] vs general anesthesia [GA]) affects the angiographic workflow applied for treatment of endovascu

300 TA, the influence of the mode of sedation on angiographic workflow during treatment for endovascular